Exploration of time points and cut-off values for early tumour shrinkage to predict survival outcomes of patients with metastatic colorectal cancer treated with first-line chemotherapy using a biexponential model for change in tumour size
-
Published:2017
Issue:5
Volume:2
Page:e000275
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Sakamaki KentaroORCID,
Kito Yosuke,
Yamazaki Kentaro,
Izawa Naoki,
Tsuda Takashi,
Morita Satoshi,
Boku Narikazu
Subject
Cancer Research,Oncology
Reference26 articles.
1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015
2. Colorectal cancer statistics, 2014;Siegel;CA Cancer J Clin,2014
3. New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, national cancer institute of the United States, National Cancer Institute of Canada;Therasse;J Natl Cancer Inst,2000
4. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial;Heinemann;Lancet Oncol,2014
5. Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC);Heinemann;Eur J Cancer,2015
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献